Permeon Biologics is a developer of therapeutic drugs for the enhancement of human health.
Permeon Biologics aims to enhance human health by using their novel Intraphilin Technology Platform™ to enable intracellular biologics as a revolutionary new generation of therapeutic drugs.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 30, 2011 | Series Unknown | $2.50M | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series Unknown |